NYSE$CYH
Community Health Systems Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Announced results for the fourth quarter and year ended December 31, 2022.
Community Health Systems, Inc. reported net operating revenues of $3.142 billion and net income attributable to Community Health Systems, Inc. stockholders of $414 million, or $3.18 per share (diluted), for the three months ended December 31, 2022. Adjusted EBITDA was $404 million, including $2 million of pandemic relief funds. On a same-store basis, admissions increased 4.4 percent and adjusted admissions increased 8.2 percent, compared to the same period in 2021.
- Net operating revenues totaled $3.142 billion.
- Net income attributable to Community Health Systems, Inc. stockholders was $414 million, or $3.18 per share (diluted).
- Adjusted EBITDA was $404 million, including $2 million of pandemic relief funds.
- Approximately $378 million principal amount of notes outstanding were extinguished during the three months ended December 31, 2022.
Headline financials
Revenue & EPS history
CHS · Revenue · Quarterly
$3.14B
Forward guidance
The Company’s projections exclude the effect of debt refinancing activities, impairment of goodwill and long-lived assets, previously recorded pandemic relief funds, the impact of any potential future divestitures, gains or losses from the sales of businesses, employee termination benefits and restructuring costs, resolution of government investigations or other significant legal settlements, costs incurred in connection with divestitures, and other significant gains or losses that neither relate to the ordinary course of business nor reflect the Company’s underlying business performance.
Tailwinds
- Net operating revenues (in millions) $ 12,200 to $ 12,600
- Adjusted EBITDA (in millions) $ 1,475 to $ 1,625
- Net loss per share—diluted $ (0.65 ) to $ (0.05 )
- Weighted-average diluted shares (in millions) 130.0 to 131.0
- Capital expenditures are projected as follows (in millions): $450 to $500
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2022
+1.7%
Avg return
Earnings day
+3.6%
Avg return
5 days after
+2.4%
Avg return
30 days after
55%
38 / 69 earnings
Positive
+52.4%
Q4 2022
Best reaction
-41.0%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.3% | +6.3% | +3.0% | |
| Q4 2025 | +5.7% | +4.5% | -13.5% | |
| Q3 2025 | +25.8% | +29.1% | -4.3% | |
| Q2 2025 | +0.0% | -0.7% | +7.7% | |
| Q1 2025 | +18.5% | +11.1% | +51.0% | |
| Q4 2024 | +7.8% | +9.9% | -22.4% | |
| Q3 2024 | -22.6% | -25.3% | -33.5% | |
| Q2 2024 | +17.5% | +27.9% | +24.9% | |
| Q1 2024 | +9.8% | +11.1% | +20.9% | |
| Q4 2023 | -28.4% | -27.7% | -11.6% | |
| Q3 2023 | -7.0% | -18.0% | +12.1% | |
| Q2 2023 | +11.8% | -8.4% | -18.9% | |
| Q1 2023 | -39.9% | -42.3% | -48.4% | |
| Q4 2022 | +52.4% | +56.3% | -0.6% | |
| Q3 2022 | +36.8% | +35.4% | +68.9% | |
| Q2 2022 | -41.0% | -39.6% | -38.6% | |
| Q1 2022 | -4.2% | -19.1% | -40.1% | |
| Q4 2021 | -10.1% | -21.3% | -15.1% | |
| Q3 2021 | +19.1% | +28.9% | +28.4% | |
| Q2 2021 | -6.4% | -8.3% | -13.1% | |
| Q1 2021 | +0.3% | +15.2% | +37.9% | |
| Q4 2020 | -7.6% | -9.3% | +28.3% | |
| Q3 2020 | +19.2% | +30.3% | +78.3% | |
| Q2 2020 | +14.2% | +26.4% | +37.8% | |
| Q1 2020 | -7.4% | -22.9% | -11.8% | |
| Q4 2019 | +42.7% | +27.8% | -44.2% | |
| Q3 2019 | -17.0% | -30.4% | -32.6% | |
| Q2 2019 | +12.9% | +25.8% | +39.7% | |
| Q1 2019 | -1.7% | -4.0% | -19.9% | |
| Q4 2018 | +12.8% | +21.4% | +8.5% | |
| Q3 2018 | -6.3% | +20.0% | +33.3% | |
| Q2 2018 | +2.3% | +9.5% | +16.7% | |
| Q1 2018 | +34.7% | +26.5% | +8.2% | |
| Q4 2017 | -11.6% | -15.0% | -31.6% | |
| Q3 2017 | -23.1% | -26.6% | -26.3% | |
| Q2 2017 | -7.8% | -8.8% | +6.9% | |
| Q1 2017 | +19.9% | +11.7% | +2.8% | |
| Q4 2016 | +33.8% | +33.6% | +21.7% | |
| Q3 2016 | +0.8% | +4.9% | +3.0% | |
| Q2 2016 | -1.5% | -0.5% | -19.3% | |
| Q1 2016 | -22.1% | — | — | |
| Q4 2015 | -22.1% | — | — | |
| Q3 2015 | -2.4% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | -7.6% | — | — | |
| Q4 2014 | +1.2% | — | — | |
| Q3 2014 | -5.0% | — | — | |
| Q2 2014 | -4.9% | — | — | |
| Q1 2014 | -7.2% | — | — | |
| Q4 2013 | +0.3% | — | — | |
| Q3 2013 | -0.3% | — | — | |
| Q2 2013 | +2.2% | — | — | |
| Q1 2013 | +4.7% | — | — | |
| Q4 2012 | +1.4% | — | — | |
| Q3 2012 | +2.4% | — | — | |
| Q2 2012 | -4.3% | — | — | |
| Q1 2012 | +5.2% | — | — | |
| Q4 2011 | +5.3% | — | — | |
| Q3 2011 | -2.7% | — | — | |
| Q2 2011 | -6.4% | — | — | |
| Q1 2010 | -3.5% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q4 2008 | +8.0% | — | — | |
| Q4 2010 | +8.0% | — | — | |
| Q3 2009 | +2.0% | — | — | |
| Q3 2010 | +2.0% | — | — | |
| Q4 2009 | +4.3% | — | — | |
| Q2 2009 | +4.3% | — | — | |
| Q2 2010 | +4.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro